Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Z160 in Subjects With Postherpetic Neuralgia

NCT01757873 is registered in ClinicalTrials.gov with Zalicus as lead sponsor.

NCT NCT01757873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01757873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Z160 in Subjects With Postherpetic Neuralgia
Lead sponsor
Zalicus
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2012
Completion date
November 30, 2013
Enrollment
144 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

postherpetic neuralgia